Viral DNA Load and Recurrence Frequency in Herpes Simplex Infection: A Three-Group Comparative Study
Keywords:
Infrastructure as Code, DevOps, Automation, ComplianceAbstract
Infrastructure as Code (IaC) has become an important approach for automating the provisioning, configuration, validation, and management of cloud and software infrastructure. This review covers five aspects of IaC: DevOps integration, security, automation, compliance, validation, and risk management. By version controlling, testing, validating, and automating the deployment of infrastructure configurations, IaC makes infrastructure changes and deployments more efficient and automated, which enables continuous integration and continuous deployment. Security considerations include misconfigurations, hardcoded secrets, inadequate access controls, vulnerable third-party modules, supply-chain attacks, and configuration drift. Infrastructure governance is reinforced by automation and compliance mechanisms that validate the infrastructure in the interest of a policy, check the compliance at runtime, and enforce the policy automatically. Automated validation embeds shift-left principles, static analysis, unit testing and policy-as-code to catch errors and violations before they reach the end-users. The other elements of risk management are identification of risk, configuration drift, vulnerability management, risk assessment, threat detection and continuous risk monitoring. In conclusion, the review underscores the importance of implementing secure, scalable, and reliable IaC practices that incorporates automation, compliance, validation, and risk management in the infrastructure lifecycle. These practices help reduce human error, ensure deployment uniformity, adhere to regulatory requirements, and enhance organizational resilience through sustainable infrastructure security, auditability, flexibility and suitability for changing operational needs.
References
World Health Organization. Herpes simplex virus. Fact sheet. Geneva: WHO; 30 May 2025. Available at: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
Harfouche M, AlMukdad S, Alareeki A, Osman AMM, Gottlieb S, Rowley J, Abu-Raddad LJ, Looker KJ. Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. Sex Transm Infect 2025;101(04):214–223. doi:10.1136/sextrans-2024-056307
Ageeb RA, Harfouche M, Chemaitelly H, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 1 in the United States: systematic review, meta-analyses, and meta-regressions. iScience 2024;27(09):110652. doi:10.1016/j.isci.2024.110652
Mehrmal S, Mojica R, Guo AM, Missall TA. Diagnostic methods and management strategies of herpes simplex and herpes zoster infections. Clin Geriatr Med 2024;40(01):147–175. doi:10.1016/j.cger.2023.09.003
Smith JB, Herbert JJ, Truong NR, Cunningham AL. Cytokines and chemokines: the vital role they play in herpes simplex virus mucosal immunology. Front Immunol 2022;13:936235. doi:10.3389/fimmu.2022.936235
Boboev SA, Agzamova SS, Palvanov KhA, Odilova GR. Interferons and IFNL3/IFNL4 gene variability in herpetic keratitis: from epithelial immunity to personalized therapy. Problems of Biology and Medicine 2025;(06/166):374–380 (in Russian)
Rizaev JA, Imamov OS, Abduvakhitova IN. Vitamin D in the prevention of recurrences of herpes-associated erythema multiforme. Problems of Biology and Medicine 2024;(04/155):420–423 (in Russian)
Herpesvirus infection: protocol for diagnosis and treatment. Clinical protocols of the Republic of Uzbekistan. Tashkent; 2024
Kamilov KhP, Kamalova MK. Modern approaches to the treatment of chronic recurrent herpetic stomatitis in children. Dostizheniya Nauki i Obrazovaniya 2018;(03/25):46–48 (in Russian)
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370(9596):1453–1457
Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21(01):128–138
Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350(01):11–20
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70(04):1–187
Aurelian L. Herpes simplex virus type 2 vaccines: new ground for optimism? Clin Vaccine Immunol 2004;11(03):437–445
Johnston C, Corey L. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev 2016;29(01):149–161
Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence 2021;12(01):2670–2702
Whitley R, Baines J. Clinical management of herpes simplex virus infections: past, present, and future. F1000Res 2018;7:F1000 Faculty Rev-1726
James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ 2020;98(05):315–329
Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 2015;10(10):e0140765
Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342(12):844–850
Tronstein E, Johnston C, Huang ML, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011;305(14):1441–1449
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Khamidova N. Kosimovna, Mirzoeva M. Rizoyevna, Qosimov O. Shodiyevich, Hamidova Nargiza Qosimovna

This work is licensed under a Creative Commons Attribution 4.0 International License.